Publication date: Jul 18, 2024

The wide spread of carbapenem-resistance clones of Acinetobacter baumannii has made it a global public problem. Some studies have shown that the prevalence of Acinetobacter baumannii clones can change over time. However, few studies with respect to the change of epidemiological clones in Acinetobacter baumannii during Corona Virus Disease 2019 (COVID-19) were reported. This study aims to investigate the molecular epidemiology and resistance mechanisms of Acinetobacter baumannii during COVID-19. A total of 95 non-replicated Acinetobacter baumannii isolates were enrolled in this study, of which 60. 0% (n = 57) were identified as carbapenem-resistant Acinetobacter baumannii (CRAB). The positive rate of the bla gene in CRAB isolates was 100%. A total of 28 Oxford sequence types (STs) were identified, of which the most prevalent STs were ST540 (n = 13, 13. 7%), ST469 (n = 13, 13. 7%), ST373 (n = 8, 8. 4%), ST938 (n = 7, 7. 4%) and ST208 (n = 6, 6. 3%). Differently, the most widespread clone of Acinetobacter baumannii in China during COVID-19 was ST208 (22. 1%). Further study of multidrug-resistant ST540 showed that all of them were carrying bla, bla, bla and bla, simultaneously, and first detected Tn2009 in ST540. The bla gene was located on transposons Tn2006 or Tn2009. In addition, the ST540 strain also contains a drug-resistant plasmid with msr(E), armA, sul1 and mph(E) genes. The prevalent clones of Acinetobacter baumannii in our organization have changed during COVID-19, which was different from that of China. ST540 strains which carried multiple drug-resistant mobile elements was spreading, indicating that it is essential to strengthen the molecular epidemiology of Acinetobacter baumannii.

Semantics

Original Article